| Disease ID | Disease name | Source of annotation with MTOR | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 616638 | SMITH-KINGSMORE SYNDROME | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | MTOR |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Type II diabetes mellitus | hsa04930 | 7.12 |
| Proteoglycans in cancer | hsa05205 | 5.02 |
| Adipocytokine signaling pathway | hsa04920 | 6.6 |
| MicroRNAs in cancer | hsa05206 | 5.38 |
| Pathways in cancer | hsa05200 | 3.98 |
| Glioma | hsa05214 | 6.66 |
| Prostate cancer | hsa05215 | 6.11 |
| ErbB signaling pathway | hsa04012 | 6.15 |
| Insulin signaling pathway | hsa04910 | 5.55 |
| Central carbon metabolism in cancer | hsa05230 | 6.7 |
| Choline metabolism in cancer | hsa05231 | 6.09 |
| Acute myeloid leukemia | hsa05221 | 6.74 |
| HIF-1 signaling pathway | hsa04066 | 5.9 |
| Thyroid hormone signaling pathway | hsa04919 | 5.82 |
| AMPK signaling pathway | hsa04152 | 5.8 |
| mTOR signaling pathway | hsa04150 | 6.72 |
| PI3K-Akt signaling pathway | hsa04151 | 4.21 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.73 |
| PI3K/AKT activation | R-HSA-198203 | 6.32 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| PI3K Cascade | R-HSA-109704 | 6.68 |
| Immune System | R-HSA-168256 | 2.37 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| GAB1 signalosome | R-HSA-180292 | 6.31 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Disease | R-HSA-1643685 | 3.33 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
| Gene Expression | R-HSA-74160 | 2.72 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
| Cellular responses to stress | R-HSA-2262752 | 4.56 |
| IRS-mediated signalling | R-HSA-112399 | 4.87 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
| CD28 co-stimulation | R-HSA-389356 | 7.98 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| Costimulation by the CD28 family | R-HSA-388841 | 6.56 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.18 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.59 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.59 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| Signaling by VEGF | R-HSA-194138 | 4.66 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Macroautophagy | R-HSA-1632852 | 6.92 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
| mTOR signalling | R-HSA-165159 | 7.7 |
| Generic Transcription Pathway | R-HSA-212436 | 3.86 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| PKB-mediated events | R-HSA-109703 | 7.66 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.28 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.52 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.73 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| Cellular response to heat stress | R-HSA-3371556 | 6.59 |
| GO term | GO ID | GO IC |
|---|---|---|
| RNA polymerase III type 1 promoter DNA binding | GO:0001030 | 8.64 |
| RNA polymerase III type 2 promoter DNA binding | GO:0001031 | 8.64 |
| RNA polymerase III type 3 promoter DNA binding | GO:0001032 | 8.64 |
| rDNA binding | GO:0000182 | 7.66 |
| TFIIIC-class transcription factor binding | GO:0001156 | 9.05 |
| purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
| RNA polymerase III regulatory region DNA binding | GO:0001016 | 8.35 |
| 5S rDNA binding | GO:0080084 | 8.64 |
| enzyme binding | GO:0019899 | 2.27 |
| macromolecular complex binding | GO:0044877 | 2.61 |
| binding | GO:0005488 | 0.18 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| nucleoside phosphate binding | GO:1901265 | 1.96 |
| nucleoside binding | GO:0001882 | 2.21 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| kinase binding | GO:0019900 | 3.32 |
| nucleotide binding | GO:0000166 | 1.96 |
| protein serine/threonine kinase activity | GO:0004674 | 3.64 |
| transferase activity | GO:0016740 | 1.95 |
| purine nucleoside binding | GO:0001883 | 2.22 |
| protein kinase activity | GO:0004672 | 3.27 |
| ribonucleoprotein complex binding | GO:0043021 | 5.15 |
| purine nucleotide binding | GO:0017076 | 2.19 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| ribosome binding | GO:0043022 | 5.83 |
| ATP binding | GO:0005524 | 2.43 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| RNA polymerase III transcription factor binding | GO:0001025 | 8.35 |
| kinase activity | GO:0016301 | 2.93 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| transcription factor binding | GO:0008134 | 3.46 |
| ribonucleoside binding | GO:0032549 | 2.22 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| protein kinase binding | GO:0019901 | 3.44 |
| catalytic activity | GO:0003824 | 1.05 |
| protein domain specific binding | GO:0019904 | 3.32 |
| small molecule binding | GO:0036094 | 1.89 |
| adenyl nucleotide binding | GO:0030554 | 2.4 |
| carbohydrate derivative binding | GO:0097367 | 2.03 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| phosphoprotein binding | GO:0051219 | 5.64 |
| phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
| adenyl ribonucleotide binding | GO:0032559 | 2.41 |
| protein binding | GO:0005515 | 0.46 |
| transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
| purine ribonucleotide binding | GO:0032555 | 2.2 |
| purine ribonucleoside binding | GO:0032550 | 2.22 |
| ribonucleotide binding | GO:0032553 | 2.19 |